Salma Parvin

592 total citations
15 papers, 259 citations indexed

About

Salma Parvin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Salma Parvin has authored 15 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in Salma Parvin's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Salma Parvin is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Salma Parvin collaborates with scholars based in United States, Bangladesh and Brazil. Salma Parvin's co-authors include Anthony Letai, Izidore S. Lossos, Mohammad Safiqul Islam, Shruti Bhatt, Francisco Vega, Kristopher A. Sarosiek, Andrew J. Gentles, Ramiro E. Verdún, Amy Brock and Ariel Ramírez-Labrada and has published in prestigious journals such as Blood, Cancer Cell and Science Signaling.

In The Last Decade

Salma Parvin

13 papers receiving 257 citations

Peers

Countries citing papers authored by Salma Parvin

Since Specialization

Citations

This map shows the geographic impact of Salma Parvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salma Parvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salma Parvin more than expected).

Fields of papers citing papers by Salma Parvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salma Parvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salma Parvin. The network helps show where Salma Parvin may publish in the future.

Co-authorship network of co-authors of Salma Parvin

This figure shows the co-authorship network connecting the top 25 collaborators of Salma Parvin. A scholar is included among the top collaborators of Salma Parvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salma Parvin. Salma Parvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients 2024 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), (unknown), (unknown), Md. Abdul Aziz, Salma Parvin, Abu Syed Md. Mosaddek, Mohammad Safiqul Islam, (unknown)	1
2	Population-based survey of the prevalence and types of glaucoma in Bangladesh 2024 ·BMJ Open Ophthalmology ·(unknown), Md Shafiqul Islam, (unknown), (unknown), Salma Parvin, (unknown), (unknown)	2
3	Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma 2024 ·Haematologica ·(unknown), Aisling Y. Coughlan, Nicola Cosgrove, (unknown), Yu Wang, Stephanie L. Gilmore, Izabela Dróźdż, Claire Comerford, Jeremy Ryan, (unknown), Salma Parvin, Michael O’Dwyer, John Quinn, Philip Murphy, Simon J. Furney, Siobhán Glavey, Tríona Ní Chonghaile	0
4	Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia 2023 ·Blood Advances ·Salma Parvin, (unknown), Shanye Yin, Geoffrey Fell, Matthew S. Davids, Catherine J. Wu, (unknown)	2
5	Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment 2021 ·Nature Cancer ·Catherine Gutierrez, Aziz Al’Khafaji, (unknown), Kaitlyn E. Johnson, Satyen H. Gohil, Ziao Lin, Binyamin A. Knisbacher, R. Durrett, Shuqiang Li, Salma Parvin, Anat Biran, Wandi Zhang, Laura Z. Rassenti, Thomas J. Kipps, Kenneth J. Livak, Donna Neuberg, Anthony Letai, Gad Getz, Catherine J. Wu, Amy Brock	57
6	Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics 2021 ·Science Signaling ·Veerle W. Daniëls, Jason J. Zoeller, Nick van Gastel, Kelley E. McQueeney, Salma Parvin, (unknown), Geoffrey Fell, (unknown), (unknown), Rajat Gupta, Johan Spetz, Patrick Bhola, Jennifer E. Endress, Isaac S. Harris, Emanuel Carrilho, Kristopher A. Sarosiek, David T. Scadden, Joan S. Brugge, Anthony Letai	22
7	Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes 2020 ·Blood Advances ·(unknown), (unknown), (unknown), Shivem B. Shah, Rishi Puri, Scott D. Butler, Vicenta Trujillo-Alonso, Matthew Teater, (unknown), (unknown), Hideki Ueno, Salma Parvin, Anthony Letai, Susan Mathew, Ankur Singh, Ethel Cesarman, Ari Melnick, Lisa Giulino‐Roth	30
8	CCR2 Expression Signature Can Classify and Predict Outcome in a Subpopulation of Chronic Lymphocytic Leukemia (CLL) Patients 2020 ·Blood ·Salma Parvin, (unknown), Matthew S. Davids, Anthony Letai	0
9	LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL 2019 ·Cancer Cell ·Salma Parvin, Ariel Ramírez-Labrada, Shlomzion Aumann, (unknown), (unknown), (unknown), Elena M. Cortizas, (unknown), (unknown), Isidro Sánchez‐García, Andrew J. Gentles, Evan R. Roberts, Daniel Bilbao, Francisco Vega, Jennifer R. Chapman, Ramiro E. Verdún, Izidore S. Lossos	48
10	Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell–dependent cytotoxicity 2017 ·Blood ·Shruti Bhatt, Salma Parvin, Yu Zhang, Hyun-Mi Cho, Kranthi Kunkalla, Francisco Vega, John M. Timmerman, Seung-Uon Shin, Joseph D. Rosenblatt, Izidore S. Lossos	25
11	Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population 2016 ·Breast Cancer ·Salma Parvin, Md. Siddiqul Islam, (unknown), Mohammad Safiqul Islam, Maizbha Uddin Ahmed, Eva Rahman Kabir, Abul Hasnat	19
12	Novel Role of LMO2 in DNA Repair Control in Diffuse Large B Cell Lymphoma 2016 ·Blood ·Salma Parvin, (unknown), (unknown), Elena M. Cortizas, Elena Cubedo, Ramiro E. Verdún, Izidore S. Lossos	1
13	Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients 2015 ·Tumor Biology ·(unknown), Mohammad Safiqul Islam, Salma Parvin, (unknown), Muhammad Shahdaat Bin Sayeed, Mir Muhammad Nasir Uddin, (unknown), Abul Hasnat	24
14	Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma 2015 ·Blood ·Shruti Bhatt, (unknown), Salma Parvin, Kristopher A. Sarosiek, Dekuang Zhao, Xiaoyu Jiang, (unknown), Anthony Letai, Izidore S. Lossos	27
15	Interleukin-21 Potently Induces Direct and Indirect Cytotoxicity of Mantle Cell Lymphoma 2014 ·Blood ·Shruti Bhatt, Kristopher A. Sarosiek, Salma Parvin, (unknown), Dekuang Zhao, Izidore S. Lossos	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact